期刊文献+

奥卡西平治疗儿童部分性发作癫痫的疗效观察 被引量:5

Therapeutic efficacy of oxcarbazepine on partial epilepsy of children
下载PDF
导出
摘要 目的观察奥卡西平治疗部分性发作癫痫患儿的疗效及不良反应。方法对2011年1月至2014年12月就诊于西安市儿童医院神经科门诊的部分性发作癫痫患儿220例,采用逐步加量方法口服奥卡西平,起始剂量为8~10mg·kg^(-1)·d^(-1),目标剂量为20~40mg·kg^(-1)·d^(-1),分2次口服;分别于服药2年、4年为时间点,随访观察比较不同时间的疗效、保留率、不良反应的差异。结果奥卡西平服药2年、4年的有效率分别为86.82%和89.42%,两组疗效差异无统计学意义(χ~2=0.652,P=0.448);服药保留率分别为86.82%和89.42%;总的发生不良反应率为8.18%,常见皮疹、嗜睡和肝功损害。结论奥卡西平治疗儿童部分性发作癫痫的疗效显著,不良反应小,保留率高,具有较好的依从性和耐受性。 Objective To observe the therapeutic efficacy and adverse reactions of oxcarbazepine on partial epilepsy of children. Methods Totally 220 children with partial epilepsy,admitted to Xi'an Children Hospital from January 2011 to December 2014,were chosen in study.They were treated with oxcarbazepine with an initial dose of 8-10 mg/( kg·d) and target dose of 20-40 mg/( kg·d),orally taking 2 times every day. The therapeutic efficacy,retention rate and adverse reactions 2 and 4 years after treatment were investigated. Results The total effective rates at 2 and 4 years after treatment were 86. 82% and 89. 42%,respectively,and the difference was not significant( χ~2= 0. 652,P = 0. 448). The retention rates at 2 and 4 years after treatment were 86. 82% and 89. 42%,respectively. The incidence of adverse reactions was 8. 18%,and the major complications included rash,drowsiness and liver damage. Conclusion Treatment with oxcarbazepine is effective with less adverse reactions and high retention rate on partial epilepsy of children,and the compliance and tolerance are high.
出处 《中国妇幼健康研究》 2016年第9期1122-1123,共2页 Chinese Journal of Woman and Child Health Research
关键词 奥卡西平 部分性发作 疗效 保留率 不良反应 oxcarbazepine(OXC) partial epilepsy therapeutic efficacy retention rate adverse reaction
  • 相关文献

参考文献5

二级参考文献46

  • 1潘映辐,陈葵,李秀华,孙迪.奥卡西平治疗癫癎的临床观察[J].临床神经病学杂志,2005,18(5):321-323. 被引量:34
  • 2中华医学会第一届全国癫痫学术会议.癫痫发作分类法(草案)[J].中华神经精神科杂志,1986,19(4):256-256. 被引量:17
  • 3Freidel M, Krause E, Kuhn K, et al. Oxcarbazepine in the treatment of epilepsy[J]. Fortschr Neurol Psychiatr, 2007,75 (2): 100-106. 被引量:1
  • 4Rufo-Campos M, Casas-Fernandez C, Martinez Bermejo A. Long- term use of oxcarhazepine oral suspension in childhood epilepsy: open-label study[J]. J Child Neurol, 2006, 21(6) :480-485. 被引量:1
  • 5Van Opstal JM,Janknegt R , Cilissen J,et al. Severe overdosage with the antiepileptie drug oxcarbazepine[J]. Br J Clin Pharmaeol ,2004,58 (3):329-331. 被引量:1
  • 6Serdaroglu G, Kurul S,Tutuneuoglu S,et al . Oxearbazepine in the treatment of childhood epilepsy[J]. Pediatr Neurol,2003,28(1):37-41. 被引量:1
  • 7Kutluay E,Mecague KD,Souza J,et al. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy[J]. Epilepsy Behav,2003,4(2):175-180. 被引量:1
  • 8Schm idt D,Sachdeo R.Oxcarbazepine for treatment of partial pilepsy:A review and recomm endations for clinical use[J].Epilepsy Behav,2000,1(6):396-405. 被引量:1
  • 9Harden CL,Kanner AM,Bautista JF,et al.Treatment-refractory epilepsy:an evidence-based approach to an tiepileptie monotherapy[J].CNS Spectr,2005,10(Suppl 3):1-3. 被引量:1
  • 10吴逊.癫癎和发作性疾病[M].北京:人民军医出版社,2001.420. 被引量:10

共引文献56

同被引文献32

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部